Women's Health

UK takes measures to tackle Utrogestan hormone replacement shortage

As supplies for Besins Healthcare’s hormone replacement therapy (HRT) medication Utrogestan (progesterone) experience shortages in the UK, the Department of…

Astellas’ nonhormonal hot flashes treatment Veozah wins FDA nod

The US Food and Drug Administration (FDA) has approved Astellas Pharma’s Veozah (fezolinetant) for use against moderate to severe vasomotor…

FDA AdCom votes unanimously in favour of OTC oral contraceptive

A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has voted unanimously in favour of giving HRA Pharma’s Opill…

US Government appeals Texas court ruling on abortion medication

The US Department of Justice (DOJ) has filed an appeal challenging a Texas court ruling suspending the US Food and…

FDA withdraws approval of preterm birth drug Makena

The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma's (Covis) Makena drug…

ImmunoGen signs loan agreement with Pharmakon for up to $175m

US-based biotechnology company ImmunoGen has signed a term loan financing facility worth up to $175m with the entities of Pharmakon…

Femtech in 2023: Covid-19 spurs interest in digital solutions

Women’s health, and the development of technologies that cater to those specific needs, has long been a neglected and underfunded…

New NHS Scheme cuts cost burden for hormone replacement therapies in the UK

On April 1, the UK Department of Health and Social Care announced the launch of a new scheme to expand…

Leading innovators in embryonic stem cell culturing for the pharmaceutical industry

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,…

TherapeuticsMD and Mayne sign product licensing agreements

Women’s healthcare company TherapeuticsMD has signed agreements for licensing its products to the Mayne Pharma affiliate in the US. According to…